Deutsche Bank analyst David Hoang initiated coverage of Harmony Biosciences (HRMY) with a Buy rating and $55 price target Maximize Your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback